Skip to main
GRDN

GRDN Stock Forecast & Price Target

GRDN Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 60%
Buy 40%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Guardian Pharmacy Service is a strong investment opportunity due to their local leadership model which allows for flexibility in responding to market needs and better serving national account clients. Their financial flexibility and strong cash flow generation make them well-positioned for growth through acquisitions in the fragmented long-term care pharmacy industry. Additionally, their focus on customer service and use of technology are key drivers for cost savings, improved patient outcomes, and payer relationships. However, potential regulatory and reimbursement changes, as well as supply chain disruptions, are key risks to consider.

Bears say

Guardian Pharmacy Service is well positioned in the fragmented long-term care pharmacy industry, with a strong suite of technology assets and an attractive offering for patients, facilities, and payors. However, their negative cash flow and high level of expenditures raise concerns about their overall financial health, and any potential regulatory or reimbursement changes could negatively impact their business and share performance. As a result, we have a negative outlook on this stock.

GRDN has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 60% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Guardian Pharmacy Services Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Guardian Pharmacy Services Inc (GRDN) Forecast

Analysts have given GRDN a Strong Buy based on their latest research and market trends.

According to 5 analysts, GRDN has a Strong Buy consensus rating as of Jun 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $43.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $43.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Guardian Pharmacy Services Inc (GRDN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.